(Q33242420)

24 July 2017

1 reference

title

General pharmacology, toxicology and future clinical development of HOE 077 (English)

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

24 October 2022

author name string

W. Horn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667670

24 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1667670

24 October 2022

publication date

1 January 1991

1 reference

full work available at URL

24 July 2017

https://api.elsevier.com/content/article/PII:016882789190009Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

https://api.elsevier.com/content/article/PII:016882789190009Z?httpAccept=text/plain

24 October 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

24 October 2022

published in

Journal of Hepatology

1 reference

24 July 2017

volume

13 Suppl 3

1 reference

24 July 2017

page(s)

S63-5

1 reference

Current therapy of chronic liver disease

24 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

24 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

Colchicine in the treatment of cirrhosis of the liver.

24 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

Is colchicine effective therapy for cirrhosis?

24 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8278(91)90009-Z

24 October 2022

Identifiers

1 reference

24 July 2017

1 reference